Not only "equipment upgrades", domestic pharmaceutical equipment enterprises still need to improve business values

　　Pharmaceutical Network Market Analysis: Into April, pharmaceutical companies annual reports have been published As of March 28, 48 pharmaceutical companies belonging to the two major pharmaceutical manufacturing and medical sectors have published their 2019 annual reports Among them, the performance of most enterprises to achieve red In addition to the joy, some pharmaceutical companies are also proposing new jobs in 2020 in their annual reports, which include equipment upgrades and technological innovations in addition to new product development
For example, pharmaceutical companies will focus on the work of the company in 2020, clearly to accelerate technological innovation Including: improve the process, improve the quality For new equipment facilities and production process requirements, to solve the problems encountered in the production process, accelerate process changes, continuously improve the quality of the company's products, accelerate equipment upgrades and equipment commissioning, quickly solve debugging problems, release design capacity, to meet the production of various varieties of individual needs and product intrinsic quality requirements   More than "equipment upgrade", the domestic pharmaceutical industry also needs to raise values (source: pharmaceutical network) policy to force the pharmaceutical industry to accelerate the transformation and upgrading Pharmaceutical companies face new challenges Pharmaceutical companies made the above-mentioned decisions are closely related to the pharmaceutical market environment, policy At present, with the "Healthy China 2030", band procurement, consistency evaluation and other policies continue to promote, the pharmaceutical market pattern has changed a lot, in promoting China's pharmaceutical innovation and transformation and upgrading, but also to pharmaceutical companies also brought certain challenges, including increased demand for production capacity, product quality improvement, cost control and so on
As the upstream of pharmaceutical enterprises, in the face of their new needs, pharmaceutical equipment enterprises should strengthen communication and communication with pharmaceutical companies to help pharmaceutical companies break through bottlenecks Such as in the production process, equipment upgrades, new technologies to increase research and development efforts to meet the pharmaceutical production capacity and product quality requirements, as well as the production of various varieties of personality needs
Industry experts in an interview with Pharmaceutical Network, said that in the drug demand increased, the quality level, the pharmaceutical enterpriseinnovation upgrade background, the future pharmaceutical equipment market demand will be steadily rising In this context, pharmaceutical enterprises should create value for customers, provide better services, in order to improve the competitiveness of enterprises
Domestic pharmaceutical machine enterprises should improve business values Active docking upstream demand At present, domestic pharmaceutical equipment enterprises in creating value for pharmaceutical enterprises generally lack of initiative and enthusiasm Pharmaceutical machine people said that, in general, pharmaceutical companies do not put forward new requirements, new ideas, equipment enterprises will rarely take the initiative to tap demand, resulting in many times pharmaceutical equipment technology, technology is too old, can not meet the needs of pharmaceutical companies
It is argued that the end of business is the choice of values The gap between Chinese pharmaceutical equipment and Europe and the United States is not limited to technology, technology, the deeper gap lies in business values, business ecology
Comparing the situation in Europe and the United States, European and American pharmaceutical enterprises in exchanges with pharmaceutical equipment enterprises, cooperation, usually discuss the pharmaceutical process, to explore whether the pharmaceutical equipment or adapt to the pharmaceutical process, European and American pharmaceutical equipment enterprises will also be around new ideas to study new processes, new equipment, and willing to spend a long time to do it Visible, domestic equipment enterprises in the initiative is still relatively lacking "Some European and American pharmaceutical equipment companies have also said that their peers in the original thinking of technological innovation is in Europe and the United States pharmaceutical companies That person said
Therefore, the starting point of technological innovation of pharmaceutical equipment enterprises should be based on the actual needs of pharmaceutical enterprises, the need to continuously improve business values, take the initiative to deeply understand the pain point of pharmaceutical enterprises and constantly solve it, in the pharmaceutical process research and development and innovation to increase efforts, and actively put forward demands and ideas to pharmaceutical equipment enterprises, to provide high-value solutions, so as to optimize the commercial ecological structure
The author learned that there are already some domestic pharmaceutical machine enterprises are working in that direction For example, in order to meet the demand for the expansion of the production capacity of pharmaceutical companies under the "4 plus 7" band procurement, some enterprises have proposed a "4 plus 7" centralized water supply overall solution The scheme can meet the water demand of six production lines in three workshops at the same time, and is built with modular design, with pasteurization, low-pressure circulation and two-way water supply functions
The relevant person in charge of the enterprise said that after the implementation of the collection policy, the system intelligence will be a major trend of future pharmaceutical production, some pharmaceutical construction standards will be more intelligent, as well as less humanized and unmanned trend development, and these are inseparable from the overall planning and consideration, the company will continue to according to the current situation of the industry, put forward more targeted overall solutions to help pharmaceutical companies increase production capacity
In 2020, "new infrastructure" is undoubtedly a hot word Among them, 5G, artificial intelligence, industrial Internet, Internet of Things as the representative of the new infrastructure has become the focus of investment, will have a significant impact on the manufacturing industry and other industries At present, the pharmaceutical industry is also moving towards automation, intelligence, information technology direction to accelerate development In this context, the pharmaceutical equipment industry should seize the opportunity as soon as possible, and pharmaceutical companies to take the initiative to explore the process, take time, time to focus on the pharmaceutical enterprises to build new and automated equipment with automation, intelligent new technology and corresponding solutions to help pharmaceutical companies transform.